Sumi et al. found that improvement of steatosis with EGCG was associated with inhibition of glutathione S-transferase-A placental form (GST-P)-positive foci, preneoplastic lesions associated with NAFLD [19]. This evidence concerns the gene GSTP1 and metabolic dysfunction-associated steatotic liver disease.